In this study we compare patients on warfarin anticoagulation but managed by two different monitoring tests.
Group 1 is monitored by Owren PT but group 2 is is monitored by the new Fiix test.
This resulted in 50 % fewer thrombotic event in the Fiix group
The answer is yes. Because the Fiix-PT improves the effectiveness of warfarin markedly without reducing safety. See the publications list for the arguments behind this statement. The cost of drugs fo
A new warfarin initiation protocol for safe Fiix dose management. J Thromb Thrombolysis A review article on anticoagulant monitoring: Oral anticoagulant monitoring: Are we on the right track? Int J L